End-of-day quote
Shanghai S.E.
06:00:00 2024-05-05 pm EDT
|
5-day change
|
1st Jan Change
|
0.135
USD
|
+5.47%
|
|
+8.87%
|
-0.74%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,000
|
4,483
|
3,628
|
3,333
|
2,888
|
2,680
|
Enterprise Value (EV)
1 |
3,058
|
4,662
|
3,881
|
3,477
|
3,054
|
2,844
|
P/E ratio
|
1,580
x
|
-18.7
x
|
-11.4
x
|
-36.2
x
|
-11
x
|
-7.84
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.09
x
|
3.65
x
|
3.37
x
|
3.06
x
|
3.09
x
|
3.11
x
|
EV / Revenue
|
2.13
x
|
3.79
x
|
3.61
x
|
3.2
x
|
3.27
x
|
3.3
x
|
EV / EBITDA
|
10.9
x
|
-67.9
x
|
-85.5
x
|
38
x
|
353
x
|
-17.3
x
|
EV / FCF
|
22.4
x
|
-102
x
|
45.8
x
|
37.9
x
|
72.7
x
|
17.3
x
|
FCF Yield
|
4.46%
|
-0.98%
|
2.19%
|
2.64%
|
1.38%
|
5.78%
|
Price to Book
|
1.51
x
|
2.71
x
|
3.16
x
|
3.06
x
|
3.46
x
|
5.7
x
|
Nbr of stocks (in thousands)
|
1,016,524
|
1,016,524
|
1,016,524
|
1,016,524
|
1,016,524
|
1,016,524
|
Reference price
2 |
3.160
|
4.950
|
4.120
|
3.710
|
3.180
|
3.030
|
Announcement Date
|
4/18/19
|
4/29/20
|
4/14/21
|
4/19/22
|
4/20/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,433
|
1,230
|
1,075
|
1,087
|
933.8
|
861.1
|
EBITDA
1 |
281.2
|
-68.67
|
-45.41
|
91.41
|
8.662
|
-164.3
|
EBIT
1 |
29.69
|
-322.9
|
-305.5
|
-118.6
|
-181.4
|
-351.1
|
Operating Margin
|
2.07%
|
-26.26%
|
-28.41%
|
-10.91%
|
-19.43%
|
-40.78%
|
Earnings before Tax (EBT)
1 |
24.01
|
-380.4
|
-554.2
|
-149.4
|
-224.5
|
-494.9
|
Net income
1 |
2.057
|
-269.4
|
-367.2
|
-104.1
|
-293
|
-393
|
Net margin
|
0.14%
|
-21.91%
|
-34.14%
|
-9.57%
|
-31.37%
|
-45.64%
|
EPS
2 |
0.002000
|
-0.2650
|
-0.3612
|
-0.1024
|
-0.2882
|
-0.3866
|
Free Cash Flow
1 |
136.5
|
-45.72
|
84.82
|
91.73
|
42.02
|
164.3
|
FCF margin
|
9.52%
|
-3.72%
|
7.89%
|
8.43%
|
4.5%
|
19.08%
|
FCF Conversion (EBITDA)
|
48.54%
|
-
|
-
|
100.34%
|
485.14%
|
-
|
FCF Conversion (Net income)
|
6,636.35%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/18/19
|
4/29/20
|
4/14/21
|
4/19/22
|
4/20/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
58.7
|
179
|
253
|
144
|
167
|
164
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.2089
x
|
-2.606
x
|
-5.572
x
|
1.573
x
|
19.23
x
|
-0.9994
x
|
Free Cash Flow
1 |
136
|
-45.7
|
84.8
|
91.7
|
42
|
164
|
ROE (net income / shareholders' equity)
|
0.32%
|
-13.1%
|
-23.4%
|
-7.31%
|
-25.6%
|
-48.8%
|
ROA (Net income/ Total Assets)
|
0.52%
|
-6.16%
|
-6.84%
|
-3.06%
|
-5.51%
|
-13.2%
|
Assets
1 |
399
|
4,371
|
5,368
|
3,404
|
5,319
|
2,979
|
Book Value Per Share
2 |
2.090
|
1.820
|
1.300
|
1.210
|
0.9200
|
0.5300
|
Cash Flow per Share
2 |
0.2200
|
0.0800
|
0.1500
|
0.0800
|
0.0500
|
0.0200
|
Capex
1 |
153
|
110
|
28.3
|
60
|
5.96
|
12.6
|
Capex / Sales
|
10.67%
|
8.97%
|
2.63%
|
5.52%
|
0.64%
|
1.46%
|
Announcement Date
|
4/18/19
|
4/29/20
|
4/14/21
|
4/19/22
|
4/20/23
|
4/29/24
|
|
1st Jan change
|
Capi.
|
---|
| +3.28% | 102B | | -2.28% | 65.53B | | +46.19% | 41.76B | | +19.68% | 38.66B | | +4.52% | 32.28B | | +9.27% | 19.57B | | +15.64% | 16.77B | | +21.26% | 15.08B | | +11.59% | 14.83B |
Other Commodity Chemicals
|